The goal is not extreme restriction
Body Composition Tracking We use inbody scan to see what you're actually losing
doi: 10.1136/gutjnl-2012-303816
Sulfonylureas remain in use because they are effective and affordable, but they are generally not preferred first-line agents due to their side-effect profile
The other is by formulating around a well-researched but relatively underused probiotic species, supported by mindfully selected complementary species for gut health, diabetes management, and metabolic improvement
If widely adopted, oral GLP-1 therapies could reshape obesity treatment, making effective medications easier to use, distribute, and integrate into long-term care